Wall Street Analysts Think Accenture (ACN) Is a Good Investment: Is It?

Accenture (ACN) currently holds an average brokerage recommendation (ABR) of 1.63, approximating a 'Buy,' based on ratings from 24 brokerage firms; however, the article suggests caution, noting that brokerage recommendations are often positively biased and may not accurately predict stock performance. With the current year Zacks Consensus Estimate for Accenture unchanged at $12.68 and a Zacks Rank of #3 (Hold), the article suggests the stock may perform in line with the broader market, advising investors to validate ABR with other indicators like Zacks Rank.

Analysis

Accenture (ACN) currently exhibits a favorable Average Brokerage Recommendation (ABR) of 1.63 on a 1 to 5 scale, derived from 24 brokerage firms, where 16 analysts rate it a Strong Buy and one a Buy, collectively representing over 70% of recommendations. However, the article cautions against relying solely on such ABRs, citing research indicating their limited success in predicting price appreciation due to inherent positive bias from brokerage firms—which reportedly issue five "Strong Buy" recommendations for every "Strong Sell." In contrast, Accenture's Zacks Consensus Estimate for current year earnings has remained unchanged at $12.68 over the past month, signaling steady but not improving earnings prospects. This, along with other factors related to earnings estimates, has led to a Zacks Rank #3 (Hold) for Accenture. The stability in earnings estimates suggests ACN may perform in line with the broader market in the near term, tempering the optimism suggested by the ABR.

Key Decisions for Investors

• Investors should exercise caution with Accenture's Buy-equivalent ABR, considering the noted potential for sell-side analyst bias and the stock's current Zacks Rank #3 (Hold).
• It is advisable to use the ABR as a supplementary data point to validate independent research or more fundamentally driven indicators like the Zacks Rank, which is based on earnings estimate revisions.
• Given the unchanged Zacks Consensus Estimate of $12.68 for Accenture and its Hold rating, a neutral stance may be warranted, monitoring for changes in earnings estimate revisions before making significant investment adjustments.